Erika Söderberg Johnson has been appointed as the new CFO and Business Controller of Biotage AB (STO:BIOTA). She will start her assignment on 1 January 2012. Erika has been the CFO of Karo Bio AB since 2007.

Mats-Olof Wallin, the present CFO of Biotage, is leaving the company at his own request and he remains at his position until Erika Söderberg Johnson starts. Mats-Olof started as CFO at Pyrosequencing AB (which later was changed to the name Biotage AB) 1 February 2003.

”Biotage has undergone many and large changes during the period Mats-Olof has been with the company, such as a number of acquisitions of both products and companies with the following post-merger work, not to forget the sale of the Biosystems division (previously known as Pyrosequencing). I want to express my gratitude for Mats-Olof’s efforts and contributions both in the role as CFO but also in the business development activities involved. I wish Mats-Olof all the best for the future.”, says Torben Jørgensen, CEO, Biotage AB.

The information in this press release is of the kind that Biotage AB (publ) may be required to make public according to the Securities Market Act and/or Financial Instruments Trading Act. The information was released for publication at 8am on October 26, 2011.

About Biotage:

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:www.biotage.com